Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences-Reference-Cited by-同舟云学术

Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences

Published:2007-09-09 Issue:10 Volume:52 Page:804-819
ISSN:1434-5161
Container-title:Journal of Human Genetics
language:en
Short-container-title:J Hum Genet

Author:

Maekawa Keiko,Saeki Mayumi,Saito Yoshiro,Ozawa Shogo,Kurose Kouichi,Kaniwa Nahoko,Kawamoto Manabu,Kamatani Naoyuki,Kato Ken,Hamaguchi Tetsuya,Yamada Yasuhide,Shirao Kuniaki,Shimada Yasuhiro,Muto Manabu,Doi Toshihiko,Ohtsu Atsushi,Yoshida Teruhiko,Matsumura Yasuhiro,Saijo Nagahiro,Sawada Jun-ichi

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/jhg2007110.pdf

Reference36 articles.

1. Bakkeren JA, De Abreu RA, Sengers RC, Gabreels FJ, Maas JM, Renier WO (1984) Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydrothymine dehydrogenase deficiency. Clin Chim Acta 140:247–256

2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

3. Cho HJ, Park YS, Kang WK, Kim JW, Lee SY (2007) Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity. Ther Drug Monit 29:190–196

4. Collie-Duguid ES, Etienne MC, Milano G, McLeod HL (2000) Known variant DPYD alleles do not explain DPD deficiency in cancer patients. Pharmacogenetics 10:217–223

5. Dobritzsch D, Schneider G, Schnackerz KD, Lindqvist Y (2001) Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil. Embo J 20:650–660

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPYD Genotyping Recommendations;The Journal of Molecular Diagnostics;2024-07

2. DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review;British Journal of Cancer;2024-06-17

3. Transcriptional profiling of human brain cortex identifies novel lncRNA-mediated networks dysregulated in amyotrophic lateral sclerosis;2024-03-19

4. Clinical Implementation of Rare and Novel DPYD Variants for Personalizing Fluoropyrimidine Treatment: Challenges and Opportunities;International Journal of Biological Sciences;2024

5. DPYDgenetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: A systematic review;2023-12-11